Related Experiment Video
Updated: Sep 30, 2026
Method for the Assessment of Effects of a Range of Wavelengths and Intensities of Red/near-infrared Light Therapy on Oxidative Stress In Vitro
Published on: March 21, 2015
Efficacy of "high-intensity" blue-light and "standard" daylight phototherapy for non-haemolytic hyperbilirubinaemia
1Department of Paediatrics, National University of Singapore, Republic of Singapore.
Insights
High-intensity blue-light phototherapy is more effective than standard daylight phototherapy for treating infant jaundice, with fewer treatment failures. While rebound is more common, it remains a low incidence.
Area of Science:
- Neonatal Medicine
- Pediatric Phototherapy
Background:
- Infant jaundice, characterized by elevated bilirubin levels, is common.
- Phototherapy is a standard treatment for neonatal hyperbilirubinemia.
Purpose of the Study:
- To compare the clinical effectiveness and outcomes of standard daylight phototherapy versus high-intensity blue-light phototherapy in infants.
- To evaluate treatment efficacy, failure rates, and rebound hyperbilirubinemia.
Main Methods:
- A clinical experience study involving 3802 infants undergoing phototherapy.
- Comparison between 3629 infants receiving standard daylight phototherapy and 173 infants receiving high-intensity blue-light phototherapy.
Main Results:
- High-intensity blue-light phototherapy demonstrated twice the effectiveness in reducing bilirubin concentrations compared to standard phototherapy.
- No treatment failures were observed with high-intensity blue-light phototherapy, versus a 1.84/1000 failure rate for daylight lamps.
- Rebound hyperbilirubinemia was more frequent after high-intensity blue-light phototherapy, necessitating a second exposure in a greater number of infants, though no third exposures were required.
Conclusions:
- High-intensity blue-light phototherapy is a highly effective treatment for infants with rapidly increasing or very high bilirubin levels.
- It is also recommended for infants inadequately responding to standard daylight phototherapy.
- Despite nursing challenges and personnel stress, infants tolerated both methods equally well.
Abstract:
We report our clinical experience with phototherapy in 3802 infants; 3629 were exposed to "standard" daylight phototherapy and 173 to "high-intensity" blue-light phototherapy. High-intensity blue-light phototherapy was twice as effective as standard daylight phototherapy in decreasing bilirubin concentrations. No failures occurred with high-intensity phototherapy compared with an overall failure rate of 1.84/1000 with daylight lamps; these cases were transferred to high-intensity phototherapy with prompt response. Rebound after cessation of phototherapy was greater in those exposed to high-intensity blue light with a significantly greater number requiring a second exposure. However, the incidence was still low. No third exposure was required in any infant. Nursing of infants under high-intensity blue light was more difficult and inconvenient as was clinical monitoring. The light also caused more stress on the nursing and medical personnel. However, the infants tolerated both types of phototherapy equally well. High-intensity blue-light phototherapy would seem to be the treatment of choice for infants with rapidly increasing or very high bilirubin levels, as well as in those not responding adequately to daylight phototherapy.
